Picture of Nykode Therapeutics ASA logo

NYKD — Nykode Therapeutics ASA News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Nykode Says On-Track To Leverage Phase 2 Cervical Cancer Data

Sept 20 (Reuters) - Nykode Therapeutics ASA  NYKD.OL :
    * NYKODE THERAPEUTICS ANNOUNCES ADVANCES IN CLINICAL
PIPELINE AND
RESEARCH
    * ON-TRACK TO LEVERAGE PROMISING PHASE 2 CERVICAL CANCER
DATA WITH
FDA CLEARANCE TO START POTENTIALLY REGISTRATIONAL TRIAL IN 2023

Source text for Eikon:  ID:nObiDsDkRa 
Further company coverage:  NYKD.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Nykode Therapeutics ASA

See all news